BASILEA PHARMACEU earnings per share and revenue

PK5 earnings per share for the last semiannual are -1.71 CHF whereas the estimation was -2.00 CHF which accounts for 14.96% surprise. รายได้ของบริษัทในช่วงเวลาเดียวกันมีจำนวน 72.86 M CHF แม้ว่าจะมีตัวเลขประมาณ 71.93 M CHF ก็ตาม Estimated earnings per share for the next semiannual are 0.94 CHF, and revenue is expected to reach 86.00 M CHF. Also watch annual changes over time to get a bigger picture of PK5 earnings per share and revenue dynamics.